2 Reasons to Buy Berkshire Hathaway Stock Now

Warren Buffett announced his retirement on May 3, 2025, and Berkshire Hathaway shares have fallen about 10% since the announcement while the S&P 500 is up ~20% over the same period. Greg Abel, now CEO, has sent a letter pledging continuity of Berkshire's culture and values, and the article argues the company's cash-rich, diversified subsidiaries and Abel's tenure justify buying the dip. The piece notes investor skepticism but frames the recent pullback as a buying opportunity; disclosure: the author holds Berkshire Hathaway and The Motley Fool also holds/recommends the stock.

Analysis

The core investment thesis is not managerial charisma but a decentralized operating model and a massive, flexible capital stack; those structural features mute execution risk when leadership changes. Second-order effects: fewer large strategic acquisitions from the parent raises acquisition opportunity for private-equity and smaller strategics (reduced bid competition), while sustained conservative underwriting will keep reinsurance capacity tight and prices supported across primary insurers.

Capital-allocation cadence is the immediate fulcrum for valuation. If the new regime favors steady buybacks and opportunistic minority stakes, per-share intrinsic value compounds faster via share-count reduction and lower effective cost of capital; if instead cash is redeployed into lower-ROIC conglomerate-style bolt-ons, the multiple will compress and margin-of-safety evaporates within 12–36 months.

Market technicals amplify short-term moves: the share-class liquidity split makes the B-line the practical trade, and passive/index flows will accentuate rallies once a visible buyback cadence or major transaction is announced. Key catalysts to watch in the next 3–9 months are stated repurchase levels, large noninsurance deployments, and operating earnings cadence from top subsidiaries — any of which can re-rate the stock by 15–30% quickly.

The consensus underestimates optionality in capital deployment post-transition: the upside is a re-rating driven by transparent, repeatable allocation (not hero investing), while the downside is a permanent impairment from a handful of poorly underwritten or low-return deals. This makes asymmetric option-like exposure attractive: own the equity or long-dated calls sized to capture re-rating, while using short-dated premium selling or put-writing to monetize elevated near-term volatility.

Key Decisions for Investors

• Long BRKB (preferred due to liquidity): initiate 2–4% portfolio position, staggered over 5–10% price bands; horizon 12–36 months. R/R: target 25–40% total return if repurchases/allocations normalize; downside 10–15% in a broad risk-off. Trim into +30% gains or if buyback guidance disappoints.
• BRKB LEAPs + covered-call financing: buy Jan-2027 BRKB calls (LEAPS) sized 0.5–1.0% notional and fund ~50% by selling 3–6 month OTM calls. Purpose: leveraged asymmetric upside to a re-rating while collecting premium to lower cost basis. Break-even if shares recover within 12–18 months; loss limited to net premium paid.
• Relative-value pair: long BRKB / short NVDA (dollar hedge ratio ~0.25–0.33) for 6–12 months to express value rotation. Rationale: capture re-rating of discount to intrinsic while partially hedging market-directional risk. Risk: tech-led rally blows out spread; keep notional of short NVDA small (max 30% of long BRKB notional).
• Income entry via put-writing: sell cash-secured BRKB puts 6–9 months out at ~12–15% OTM to collect premium and establish a lower-cost basis. If assigned, you acquire at a price ~12–15% below today with premium collected; risk is assignment into a deeper market sell-off — size at 1–2% of portfolio per strike.